Case Study: SureClinical speeds pharmaceutical trials with Thales e-Security HSMs

Sureclinical Speeds And Simplifies Pharmaceutical Trials – With Thales HSMs Securing the Root of Trust

SureClinical wanted to modernize pharmaceutical trials by replacing slow, paper-intensive document handling with a cloud-based process. The startup needed a way to secure clinical documents and digital signatures in a highly regulated industry where trust, compliance, and auditability were essential.

SureClinical built its cloud digital signing solution with Thales e-Security HSMs, using Thales nShield Connect HSMs to protect the root of trust and support Adobe document signing and verification. The system was validated for use in pharmaceutical trials, met requirements including FIPS 140-2 Level 3, FDA 21 CFR Part 11, European Commission Annex 11, and HIPAA, and helped customers save as much as $200,000 per year in shipping charges while accelerating time to market.

SureClinical